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Introduction
•  Peripancreatic fluid collections (PFCs) are one  
of the most common complications of acute 
pancreatitis. 
•  The majority of PFCs resolve spontaneously, the 
rest form mature cysts filled with either necrotic 
debris or with fluid, classified as walled off 
pancreonecrosis (WOPN) and pancreatic 
pseudocysts (PP) respectively. 
•  Electrocautery enhanced AXIOS™ lumen-
apposing metal stents (EEAL) has primed EUS 
guided drainage as a treatment of choice for PFCs.
Methods
•  IRB approved retrospective chart review of EEAL 
performed at a large quaternary care center. 
•  Procedural data including technical and clinical 
success rate were collected and analyzed. 
•  Clinical success rate was measured by symptoms 
resolution at first outpatient office visit and by 
cyst resolution (complete, incomplete (>50%)  
or partial (<50%).
Results
•  38 patients underwent 51 EEAL procedures for 
the treatment of PFCs. 
•  92.2% of the cysts were at least 6cm in diameter. 
•  11 patients required multiple EEAL placement, of 
whom 7 patients had multiple cysts requiring 
separate treatments, 2 patients had reoccurrence 
of the cysts requiring drainage, 1 patient required 
2 EEAL placed for one large septated cyst and 
1 patient required 2 attempts to place the stent. 
•  Technical success rate was 96.1%, 2 times 
EEAL angulated during placement (stent 
dislodgment to the stomach, stent placement  
to the fluid surrounding the PFCs) 
•  Only after 5 interventions (9.8%) patients didn’t 
experience any clinical improvement post-
procedurally of which 2 required surgical 
intervention, 2 had cyst reoccurrence and  
1 had stent placement in the pericystic area. 
•  The average hospital stay after EEAL placement 
was 7.89 days with a mean of 3.5 days.
Conclusion
Our data demonstrates safety and efficacy of 
EEAL use in the treatment of PFCs with a high 
technical success rate of 96.1%. Over 90% of 
patients experienced partial or complete resolution 
of their symptoms and 83.4% had at least 50% of 
cyst size reduction was noted. Larger studies in 
this area is needed to prove EEAL’s superiority 
over more traditional methods of treating PFCs.
Mean age 54.5 (22-75) yo
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